211 related articles for article (PubMed ID: 26389799)
1. Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology.
Ammann RW; Stumpe KD; Grimm F; Deplazes P; Huber S; Bertogg K; Fischer DR; Müllhaupt B
PLoS Negl Trop Dis; 2015; 9(9):e0003964. PubMed ID: 26389799
[TBL] [Abstract][Full Text] [Related]
2. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
Stumpe KD; Renner-Schneiter EC; Kuenzle AK; Grimm F; Kadry Z; Clavien PA; Deplazes P; von Schulthess GK; Muellhaupt B; Ammann RW; Renner EL
Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583
[TBL] [Abstract][Full Text] [Related]
3. Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976-2001).
Ammann RW; Renner EC; Gottstein B; Grimm F; Eckert J; Renner EL;
J Hepatol; 2004 Oct; 41(4):551-9. PubMed ID: 15532108
[TBL] [Abstract][Full Text] [Related]
4. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis.
Caoduro C; Porot C; Vuitton DA; Bresson-Hadni S; Grenouillet F; Richou C; Boulahdour H; Blagosklonov O
J Nucl Med; 2013 Mar; 54(3):358-63. PubMed ID: 23303963
[TBL] [Abstract][Full Text] [Related]
5. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study.
Bresson-Hadni S; Blagosklonov O; Knapp J; Grenouillet F; Sako Y; Delabrousse E; Brientini MP; Richou C; Minello A; Antonino AT; Gillet M; Ito A; Mantion GA; Vuitton DA
Liver Transpl; 2011 Jul; 17(7):855-65. PubMed ID: 21455928
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a structured treatment discontinuation in patients with inoperable alveolar echinococcosis on long-term benzimidazole therapy: A retrospective cohort study.
Deibel A; Stocker D; Meyer Zu Schwabedissen C; Husmann L; Kronenberg PA; Grimm F; Deplazes P; Reiner CS; Müllhaupt B
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010146. PubMed ID: 35089933
[TBL] [Abstract][Full Text] [Related]
7. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up.
Crouzet J; Grenouillet F; Delabrousse E; Blagosklonov O; Thevenot T; Di Martino V; Piarroux R; Mantion GA; Bresson-Hadni S
Clin Microbiol Infect; 2010 Jun; 16(6):788-91. PubMed ID: 19912267
[TBL] [Abstract][Full Text] [Related]
8. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients.
Bresson-Hadni S; Koch S; Beurton I; Vuitton DA; Bartholomot B; Hrusovsky S; Heyd B; Lenys D; Minello A; Becker MC; Vanlemmens C; Mantion GA; Miguet JP
Hepatology; 1999 Oct; 30(4):857-64. PubMed ID: 10498634
[TBL] [Abstract][Full Text] [Related]
9. Structured treatment interruption in patients with alveolar echinococcosis.
Reuter S; Buck A; Manfras B; Kratzer W; Seitz HM; Darge K; Reske SN; Kern P
Hepatology; 2004 Feb; 39(2):509-17. PubMed ID: 14768005
[TBL] [Abstract][Full Text] [Related]
10. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity.
Azizi A; Blagosklonov O; Lounis A; Berthet L; Vuitton DA; Bresson-Hadni S; Delabrousse E
Abdom Imaging; 2015 Jan; 40(1):56-63. PubMed ID: 24970734
[TBL] [Abstract][Full Text] [Related]
11. AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity.
Brumpt E; Blagosklonov O; Calame P; Bresson-Hadni S; Vuitton DA; Delabrousse E
Infection; 2019 Dec; 47(6):955-960. PubMed ID: 31165442
[TBL] [Abstract][Full Text] [Related]
12. Stereological evaluation of treatment response in patients with non-resectable hepatic alveolar echinococcosis using computed tomography via the Cavalieri method.
Aydinli B; Kantarci M; Polat KY; Unal B; Atamanalp SS; Durur I; Unal D; Akgun M
Liver Int; 2006 Dec; 26(10):1234-40. PubMed ID: 17105589
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of liposomal albendazole for the treatment of the patients with complex alveolar echinococcosis: a comparative analysis of CEUS, CT, and PET/CT.
Li H; Song T; Qin Y; Liu W; Li X; Shao Y; Wen H
Parasitol Res; 2015 Nov; 114(11):4175-80. PubMed ID: 26239800
[TBL] [Abstract][Full Text] [Related]
14. Late biliary complications in human alveolar echinococcosis are associated with high mortality.
Frei P; Misselwitz B; Prakash MK; Schoepfer AM; Prinz Vavricka BM; Müllhaupt B; Fried M; Lehmann K; Ammann RW; Vavricka SR
World J Gastroenterol; 2014 May; 20(19):5881-8. PubMed ID: 24914349
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-Weighted MRI for the Initial Viability Evaluation of Parasites in Hepatic Alveolar Echinococcosis: Comparison with Positron Emission Tomography.
Zheng J; Wang J; Zhao J; Meng X
Korean J Radiol; 2018; 19(1):40-46. PubMed ID: 29353998
[TBL] [Abstract][Full Text] [Related]
16. Outcomes After Liver Resection for Hepatic Alveolar Echinococcosis: A Single-Center Cohort Study.
Joliat GR; Melloul E; Petermann D; Demartines N; Gillet M; Uldry E; Halkic N
World J Surg; 2015 Oct; 39(10):2529-34. PubMed ID: 26067633
[TBL] [Abstract][Full Text] [Related]
17. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography.
Ehrhardt AR; Reuter S; Buck AK; Haenle MM; Mason RA; Gabelmann A; Kern P; Kratzer W
Abdom Imaging; 2007 Nov; 32(6):730-6. PubMed ID: 17285403
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET.
Reuter S; Grüner B; Buck AK; Blumstein N; Kern P; Reske SN
Nuklearmedizin; 2008; 47(4):147-52. PubMed ID: 18690373
[TBL] [Abstract][Full Text] [Related]
19. PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis.
Husmann L; Muehlematter UJ; Grimm F; Ledergerber B; Messerli M; Kudura K; Gruenig H; Muellhaupt B; Hasse B; Huellner MW
Parasitol Int; 2021 Aug; 83():102356. PubMed ID: 33872794
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET/MRI imaging for the management of alveolar echinococcosis: initial clinical experience at a reference centre in Austria.
Lötsch F; Waneck F; Groger M; Auer H; Kaczirek K; Rausch I; Wadsak W; Hacker M; Lagler H; Ramharter M; Karanikas G
Trop Med Int Health; 2019 Jun; 24(6):663-670. PubMed ID: 30851233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
